Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5977_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
12.10.2026
Размер:
7 Мб
Скачать
☆
4.11 The Production of Other Novel Alginate Fibers 73
Table 4.11 Silver concentrations in contact solutions.
Duration of contact
Silver concentration in
contact solution (ppm)
Normal saline Human serum
30 minutes 0.50 2.18
48 hours 0.40 2.74
7days 1.32 3.74
Pseudomonas aeruginosa
0.01
0.1
1
10
100
1000
10 000
100 000
020406080
Time (hours)
Log percentage recovery
Sorbsan
Urgo sor b
Aquacel
Alginate+Ag
Figure 4.9 The antimicrobial action of silver-containing alginate fibers against
Pseudomonas aeruginosa. Adapted with permission from Qin [43].
surface of the bers can also be detached from the bers and get into the wound
exudate.
Table 4.11 shows the silver ion concentration when alginate ber containing 1%
AlphaSan RC5000 isplaced in contact with normalsaline or human serum. Itcan be
seen that the silver ions are slowly released into the solution, acting as an antimicro-
bial agent. More silver ions can be seen released into human serum, suggesting the
high silver binding abilities of the protein components in the wound exudates [43].
Figure 4.9 shows the antimicrobial action of silver-containing alginate bers
against Pseudomonas aeruginosa. There was 100% reduction in bacteria count
within ve hours when the bers were placed in contact with solutions containing
the bacteria. Under similar test conditions, the silver-containing alginate bers had
a far better antimicrobial eect than other common types of alginate bers [43].
4.11 The Production of Other Novel Alginate Fibers
From a wet-spinning point of view, the production process for alginate bers is one
of the cleanest processes used for man-made bers. The dissolution of sodium algi-
nate takes place in pure water and at neutral pH, while coagulation can take place
in a dilute aqueous CaCl
2
solution, again at a neutral pH and under room temper-
ature. This makes it easy for alginate to be used as a carrier for biologically active
74 4 The Production of Fibers From Alginate
compounds that can be added to the bers and still maintain their bioactivities in
the nished bers.
Fan et al. [16] prepared bers from alginate and gelatin blends by spinning their
solution through a viscose-type spinneret into a coagulation bath containing aque-
ous CaCl
2
and ethanol. The highest tensile strength was obtained when the gelatin
content was 30 wt% of the overall solid content. The water-retention values of the
blend bers increase with the increase in gelatin contents. There was strong inter-
action and good miscibility between alginate and gelatin molecules, as a result of
intermolecular hydrogen bonds.
Wang et al. [62] prepared bers from blends of alginate and soy protein by spin-
ning their solution through a viscose-type spinneret into a novel coagulation bath
containing aqueous CaCl
2
, HCl, and ethanol. Fibers with 10% soy protein isolate
had a tensile strength of 14.1 cN/tex in the dry state and 3.46 cN/tex in the wet state,
respectively, with elongation at break of 20.71% and 56.7%, respectively.
Kobayashi et al. [31] used alginate bers for enzyme immobilization. They spun
an aqueous mixture of sodium alginate and enzymes into divalent metallic ion
solution as a coagulation bath to produce enzyme-containing bers. The entrap-
ment yields of enzymes, such as glucoamylase, cyclodextrin glucanotransferase,
endo-polygalacturonase, and protease, were higher in the calcium alginate bers
than those found in calcium alginate beads made under similar conditions. It was
found that the yields increased with the increase in the extrusion rate through
the spinning nozzle because at a higher extrusion rate, the polymeric molecules are
more highly oriented along the ber axis, which can help prevent leakage of the
entrapped enzymes.
Polymer blending is a useful tool for the functional modication of alginate
bers and the resultant properties can be tailored for their applications in wound
dressings, cosmetic products, baby diapers, adult incontinence products, feminine
hygiene products, and other functional medical and hygiene materials where
specic functional performances are required. As been pointed out previously,
the blending of alginate with carboxymethyl cellulose is proven highly eec-
tive in enhancing the gelling properties of alginate bers whilst the addition of
silver-containing particles into alginate bers produces silver-containing alginate
bers with strong antimicrobial properties. In recent years, there have been many
attempts to combine alginate with chitosan through many dierent techniques
in order to generate bers that have the high absorbency of alginate bers and
strong antimicrobial performance of chitosan, thus possessing two key properties
important for medical and healthcare products.
Watersoluble derivativesof chitosan such as carboxymethyl chitosan and hydrox-
ypropyl chitosan can be mixed with aqueous sodium alginate solution to prepare
a homogeneous spinning solution which can be spun into a polyblend ber con-
taining both alginate and chitosan. Fan et al. [18] were able to prepare bers that
contain 10–70% carboxymethyl chitosan with antimicrobial properties. When the
carboxymethyl chitosan content was 30%, the tensile strength of the polyblend ber
was 13.8 cN/tex [17]. Jiang et al. [28] showed that the addition of carboxymethyl chi-
tosan can signicantly increase the absorption properties of alginate bers. Hu et al.
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
4.11 The Production of Other Novel Alginate Fibers 75
[26] and Chang et al. [14] used co-electrospinning technique to combine alginate
and chitosan in the same polyblend ber.
Qin [47] developed a novel process whereby alginate and chitosan can be uni-
formly dispersed in the same spinning solution. In this process, an acid-resistant
derivative of alginate, propylene glycol alginate (PGA), was rst dissolved in water
and then mixed with an acidic chitosan solution. PGA is an esteried derivative of
alginate with excellent emulsifying properties, which is esteried with propylene
oxide at 70
∘
C under pressure with alkali as catalyst [37, 57]. Figure 4.10 shows a
schematic illustration of theconversionof alginic acid intopropyleneglycol alginate.
Because the carboxylic acid groupis esteried by propylene glycol to yield an ester
group, PGA is soluble in water while remaining stable in acidic environment upto
pH 3–4, when sodiumalginate would precipitate out as alginic acid. This toleranceto
acidic environment together with its strong salt resistance makes PGA highly valu-
able in foodstus and beverages with strong acidity and high levels of metallic ions
such as calcium and sodium, where PGA is able to improve the stability of acid in
foodstu and also prevent the lay down created by calcium and other high valued
metallic ions. In thespinning of the mixedsolution of PGA and chitosan,upon extru-
sion into an alkaline coagulation bath, chitosan precipitates out to form laments
that contain PGA, and during the subsequent processing, part of the ester groups in
PGA are hydrolyzed to generatecarboxylic acid groups that can hold a large amount
of water, with some ester groups reacting with the amine groups in chitosan to form
a cross-linked structure that helps to maintain a stable ber structure.
OH
OH
H
H
H
H
H
H
H
H
HH
H
H
H
H
H
H
H
H
4
1
1
1
4
4
4
1
GG
MM
H
H
O
O
O
O
O
O
–
O
–
O
–
O
–
O
O
O
–
O
O
O
O
OH
OH
OH
OH
O
OH
OH
HO
HO
α
β
β
α
OH
O
O
O
O
O
OH
O
O
O
–
O
–
HO
HO
OH
O
O
O
O
O
OH
H
H
H
H
H
H
H
H
HH
H
H
H
H
H
H
H
H
4
1
1
1
4
4
4
1
GG
MM
H
H
O
O
O
α
β
β
α
CH
2
CH
3
CH
CH
2
CH
3
CH
CH
2
CH
3
CH
CH
2
CH
3
CH
O
OH
OH
CH
2
CH
3
CH
OH
OH
Figure 4.10 Schematic illustration of the conversion of alginic acid into propylene glycol
alginate.
76 4 The Production of Fibers From Alginate
Table 4.12 Gel swelling ratio of propylene glycol alginate/chitosan
polyblend fibers.
Ratio between PGA and chitosan (g/g) Gel swelling ratio (g/g)
In de-ionized water In saline
0 : 100 2.91 2.88
5 : 100 3.45 3.10
10 : 100 4.57 4.15
20 : 100 5.78 4.65
30 : 100 7.65 5.22
Table 4.12 shows the gel swelling ratio of propylene glycol alginate/chitosan
polyblend bers made with dierent proportions of these two polymers. It can be
seen that the gel swelling ratio increases with the increased use of propylene glycol
alginate.
4.12 Historical Development of Alginate Fibers
Since the rst attempt to produce bers from alginate, there have been many appli-
cations of these bers. In the early stages of development, alginate bers were used
principally in the productionof water-soluble yarns that would dissolvein a scouring
process. These yarns were used as a support during the manufacture of ne lace, or
as draw threads in the production of hosiery. Fabrics from alginate bers were once
produced commercially for their re-resistant property, because of the high content
of metal ions in the ber [12, 13]. Alginate bers were also used for the manufacture
of bags used for the transportation of soiled hospital linen that was designed to dis-
solve in the wash. However, by the 1970s, they were replaced for these applications
by cheaper synthetic bers.
The rst person in modern times to recognize the potential valueof alginate bers
in surgery and wound management was George Blaine, a major in the Royal Army
Medical Corps. He showed them to be absorbable in tissue, sterilizable by heat, and
compatible with penicillin [8]. He also described how he had used alginate lms
clotted in situ for the treatment of wounds and burns in troop ship hospitals in the
Far East and described the use of alginate, sometimes in combination with plasma
as an alginate-plasma lm, as “puncture patches” over septal defects.
During a subsequent assessment of the use of alginate as hemostats and wound
dressings, Blaine reported their apparent lack of toxicity following a series of
animal studies in which bers were implanted into animal tissues, and gels made
from alginate were used to treat experimentally produced burns [9]. Successful
use of alginate-derived materials in aural surgery and neurosurgery was reported
by Oliver and Blaine [38]. Bray et al. [11] described the results of a three-month
trial into the use of alginate in the casualty department of Croydon Hospital where
alginates in the form of lms, wool, gauzes, and clots formed in situ by mixing
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
4.12 Historical Development of Alginate Fibers 77
sterile solutions of calcium chloride and sodium alginate, were applied to a wide
range of wounds, including burns, lacerations, ulcers, and amputations. In all cases,
healing was rapid and uneventful. By the late 1940s and early 1950s, alginates were
being used in some 70 hospitals in the UK over a range of surgical specialties [10].
The revival of alginate bers began with a new theory in wound management.
Although it has a long history, the standard practice in wound management
remained fairly static until Winter published his work in 1962 on acute supercial
wounds in the domestic pig [43, 50], which showed that wounds covered with a
lm dressing maintained a moist environment and healed faster than those left to
dry out, heralding the advent of modern wound dressings based on the principle
of moist healing [46, 47]. In the early 1980s, as wound dressings based on the
moist healing principle were expanding, alginate bers and nonwoven fabrics
were found to have unique gel-forming characteristics whereby on contact with
wound exudates, sodium ions in the exudates can exchange with calcium ions in
the bers, and as the ion-exchange process proceeds, the bers absorb more and
more water to form a brous gel. For the alginate wound dressings, as water enters
the ber structure, the entire textile structure is transformed into a sheet of moist
gel, thus providing an ideal moist healing environment for the underlining wound.
Many clinical trials have shown that alginate wound dressings not only have the
high absorption capacities but also possess the ability to promote wound healing.
In order to further improve its clinical ecacy, many attempts have been made
to improve the alginate bers and wound dressings. Table 4.13 summarized ve
generations of alginate bers for the production of wound dressings.
Table 4.13 A summary of five generations of alginate fibers for the production of wound
dressings.
Stage Product Product characteristics Main brand
1G Calcium alginate ber Gelling bers made from high M
calcium alginate bers [63]
Sorbsan
TM
2G Calcium sodium
alginate ber
High absorption bers made
from high G calcium sodium
alginate bers [48]
Kaltostat
TM
3G Alginate/CMC
polyblend ber
Highly absorbent and
gel-forming bers made from a
mixture of alginate and sodium
carboxymethyl cellulose [45]
UrgoSorb
TM
4G Silver-containing
alginate ber
Antimicrobial alginate bers and
wound dressings containing
silver [41, 52]
UrgoSorb Silver
TM
5G Alginate and chitosan
polyblend ber
Highly absorbent and
antimicrobial bers and wound
dressings that combine the
unique properties of alginate and
chitosan [44, 49, 58]
GellinS
TM
78 4 The Production of Fibers From Alginate
4.13 Summary
Alginate is a natural polysaccharide with abundant supply in nature. By processing
alginate into bers, it is possible to obtain novel biomaterials that can be processed
further into woven, knitted, nonwoven, and many other forms of composite struc-
tures. Because it is a polymeric acid, alginate bers can be used as a carrier to deliver
zinc, silver, and other bioactive metal ions for wound care and other novel applica-
tions. In addition, since it is processed in an aqueous solution and in an aqueous
coagulation bath at a neutral pH, many bioactive materials such as enzymes can be
combined into the alginate bers to produce enhanced bioactivities.
References
1 Agren, M.S. (1993). Zinc oxide increases degradation of collagen in necrotic
wound tissue. Br. J. Dermatol. 129 (2): 221–226.
2 Agren, M.S. (1999). Zinc in wound repair. Arch. Dermatol. 135 (10): 1273–1274.
3 Agren, M.S. and Mirastschijski, U. (2004). The release of zinc ions from and
cytocompatibility of two zinc oxide dressings. J. Wound Care 13 (9): 367–369.
4 Annison, G., Cheetham, N.W.H., and Couperwhite, I. (1983). Determination of
the uronic acid composition of alginates by high-performance liquid chromatog-
raphy. J. Chromatogr. 204: 137–143.
5 Atkins, E.D.T., Nieduszynski, I.A., Mackie, W. et al. (1973). Structural com-
ponents of alginic acid. 1. Crystalline structure of poly-β-D-mannuronic acid.
Results of x-ray diraction and polarized infrared studies. Biopolymers 12:
1865–1878.
6 Atkins, E.D.T., Nieduszynski, I.A., Mackie, W. et al. (1973). Structural compo-
nents of alginic acid. 2. Crystalline structure of poly-α-L-guluronic acid. Results
of x-ray diraction and polarized infrared studies. Biopolymers 12: 1879–1887.
7 Bixler, H.J. and Porse, H. (2011). A decade of change in the seaweed hydrocol-
loids industry. J. Appl. Phycol. 23 (3): 321–335.
8 Blaine, G. (1946). The use of plastics in surgery. Lancet 1946: 525–552.
9 Blaine, G. (1947). Experimental observations on absorbable alginate products in
surgery. Ann. Surg. 125 (1): 102–114.
10 Blaine, G. (1951). A comparative evaluation of absorbable haemostatics. Postgrad.
Med. J. 27: 613–620.
11 Bray, C., Blaine, G., and Hudson, P. (1948). New treatment for burns, wounds
and haemorrhage. Nurs. Mirror 86: 239–242.
12 Chamberlain, N.H., Johnson, A., and Speakman, J.B. (1945). Some properties of
alginate rayons. J. Soc. Dye. Colour. 61 (1): 13–20.
13 Chamberlain, N.H., Lucas, F., and Speakman, J.B. (1949). The action of light on
calcium alginate rayon. J. Soc. Dye. Colour. 65 (12): 682–692.
14 Chang, J., Lee, Y.H., Wu, M.H. et al. (2012). Electrospun anti-adhesion barrier
made of chitosan alginate for reducing peritoneal adhesions. Carbohydr. Polym.
88: 1304–1312.
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
References 79
15 Dealey, C. (1994). TheCareofWounds. Oxford: Blackwell Science Ltd.
16 Fan, L., Du, Y., Huang, R. et al. (2005). Preparation and characterization of
alginate/gelatin blend bers. J. Appl. Polym. Sci. 96 (5): 1625–1629.
17 Fan, L., Du, Y., Zhang, B. et al. (2005). Antibacterial bers made of calcium algi-
nate/chitosan derivative composite. J. Funct. Polym. 18 (3): 34–38.
18 Fan, L., Du, Y., Zhang, B. et al. (2006). Preparation and properties of algi-
nate/carboxymethyl chitosan blend bers. Carbohydr. Polym. 65: 447–452.
19 Furr, J.R., Russell, A.D., Turner, T.D. et al. (1994). Antibacterial activity of Acti-
sorb Plus, Actisorb and silver nitrate. J. Hosp. Infect. 27 (3): 201–208.
20 Grant, G.T., Morris, E.R., Rees, D.A. et al. (1973). Biological interactions between
polysaccharides and divalent cations: the egg-box model. FEBS Lett. 32: 195–198.
21 Grasdalen, H., Larsen, B., and Smidsrod, O. (1979). Study of the composition and
sequence of uronate residues in alginates. Carbohydr. Res. 68: 23–31.
22 Haug, A. and Larsen, B. (1962). Quantitative determination of the uronic acid
composition of alginates. Acta Chem. Scand. 16: 1908–1918.
23 Haug, A., Larsen, B., and Smidsrod, O. (1966). A study of the constitution of
alginic acid by partial acid hydrolysis. Acta Chem. Scand. 20: 183–190.
24 Haug, A., Larsen, B., and Smidsrod, O. (1967). Correlation between chemical
structure and physical properties. Acta Chem. Scand. 21: 768–778.
25 Haug, A., Larsen, B., and Smidsrod, O. (1974). Uronic acid sequence in alginate
from dierent sources. Carbohydr. Res. 32: 217–225.
26 Hu, W. and Yu, H. (2013). Coelectrospinning of chitosan/alginate bers by
dual-jet system for modulating material surfaces. Carbohydr. Polym. 95: 716–727.
27 Ji, M.H. (1984). Studies on the M:G ratios in alginate. Hydrobiologia 116 (117):
554–556.
28 Jiang, L., Kong, Q., Ji, Q. et al. (2007). Study on preparation and properties of
sodium alginate/water-soluble chitin blend ber. Synth. Fibres China (12): 12–15.
29 Klasen, H.J. (2000). Historical review of the use of silver in the treatment of
burns. I. Early uses. Burns 26 (2): 117–130.
30 Klasen, H.J. (2000). Historical review of the use of silver in the treatment of
burns. II. Renewed interest for silver. Burns 26 (2): 131–138.
31 Kobayashi, Y., Matsuo, R., Ohya, T. et al. (1987). Enzyme-entrapping behaviors in
alginate bers and their papers. Biotechnol. Bioeng. 30 (3): 451–457.
32 Kobayashi, Y., Kamishima, H., Fukuoka, S., et al. (1995). Water soluble alginate
bers. US Patent 5,474,781.
33 Lansdown, A.B.G. (2002). Silver 2: toxicity in mammals and how its products aid
wound repair. J. Wound Care 11 (5): 173–177.
34 Lansdown, A.B.G., Jensen, K., and Jensen, M.Q. (2003). Contreet hydrocolloid
and Contreet foam: an insight into new silver-containing dressings. J. Wound
Care 12 (6): 205–210.
35 Le, Y., Anand, S.C., and Horrocks, A.R. (1997). Using alginate ber as drug
carrier for wound dressing. In:
Medical Textiles’96 (ed. S.C. Anand), 21–26.
Cambridge: Woodhead Publishing Ltd.
36 McDowell, R.H. (1960). Applications of alginates. Rev. Pure Appl. Chem. 10: 1–19.
80 4 The Production of Fibers From Alginate
37 Noto, V.H. and Pettitt, D.J. (1980). Production of propylene glycol alginic acid
esters. British Patent 1563019.
38 Oliver, L.C. and Blaine, G. (1950). Haemostasis with absorbable alginates in neu-
rosurgical practice. Br.J.Surg.37: 307–310.
39 Onsoyen, E. (1992). Alginates. In: Thickening and Gelling Agents for Food (ed.
A. Imeson), 1–24. Glasgow: Blackie Academic and Professional.
40 Penman, A. and Sanderson, G.R. (1972). A method for the determination of
uronic acid sequence in alginates. Carbohydr. Res. 25: 280–285.
41 Qin, Y. (2005). Calcium sodium alginate bers. Chem. Fibers Int. 55 (2): 98–99.
42 Qin, Y. (2005). The ion exchange properties of alginate bers. Te xt . Res. J. 75 (2):
165–168.
43 Qin, Y. (2005). Silver containing alginate bers and dressings. Int. Wound J. 2(2):
172–176.
44 Qin, Y. (2006). The characterization of alginate wound dressings with dierent
ber and textile structures. J. Appl. Polym. Sci. 100 (3): 2516–2520.
45 Qin, Y. (2008). Alginate bres: an overview of the production processes and
applications in wound management. Polym. Int. 57 (2): 171–180.
46 Qin, Y. (2014). Preparation method and applications of chitosan bers modied
by oxidized alginate. Chinese Patent Zl201310127978.X.
47 Qin, Y. (2015). Preparation methods and applications of polyblend bers from
chitosan and propylene glycol alginate. Chinese Patent Zl201210553968.8.
48 Qin, Y. (2016). Medical Textile Materials, 89–107. Cambridge: Elsevier.
49 Qin, Y. and Gilding, D.K. (2000). Fibers of Cospun alginates, US Patent
6,080,420.
50 Qin, Y. and Groocock, M.R. (2007). Polysaccharide bers. US Patent 7,229,689
B2.
51 Qin, Y., Agboh, C., Wang, X. et al. (1996). Alginate bers. Chem. Fibers Int. 46:
272–273.
52 Qin, Y., Hu, H., and Luo, A. (2006). The conversion of calcium alginate bers
into alginic acid bers and sodium alginate bers. J. Appl. Polym. Sci. 101 (6):
4216–4221.
53 Smidsrod, O. and Haug, A. (1972). Dependence upon the gel-sol state of the
ion-exchange properties of alginates. Acta Chem. Scand. 26: 2063–2074.
54 Smidsrod, O., Haug, A., and Whittington, S.G. (1972). The molecular basis for
some physical properties of polyuronides. Acta Chem. Scand. 26: 2563–2564.
55 Speakman, J.B. and Chamberlain, N.H. (1944). The production of rayon from
alginic acid. J. Soc. Dye. Colour. 60: 264–272.
56 Stanford E C (1881). Improvements in the manufacture of useful products from
seaweeds. British Patent 142.
57 Steiner, A.B. (1947). Manufacture of glycol alginates. US Patent 2426215.
58 Stevens, J. and Chaloner, D. (2005). Urgosorb dressing: management of acute
and chronic wounds. Br.J.Nurs.14 (15): S22–S28.
59 Thomas, S. and McCubbin, P. (2003). A comparison of the antimicrobial eects
of four silver-containing dressings on three organisms. J. Wound Care 12 (3):
101–107.
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
References 81
60 Thomas, S. and McCubbin, P. (2003). An in vitro analysis of the antimicrobial
properties of 10 silver-containing dressings. J. Wound Care 12 (8): 305–308.
61 Thomas, A., Gilson, C.D., and Ahmed, T. (1995). Gelling of alginate bers. J.
Chem. Technol. Biotechnol. 64: 73–77.
62 Wang, Q., Du, Y., Hu, X. et al. (2006). Preparation of alginate/soy protein iso-
late blend bers through a novel coagulating bath. J. Appl. Polym. Sci. 101 (1):
425–431.
63 Winter, G.D. (1962). Formation of the scab and the rate of epithelialization of
supercial wounds in the skin of the young domestic pig. Nature 193: 293–294.
64 Woodward, F. (1951). The Scottish seaweed research association. J. Mar. Biol.
Assoc. U. K. 29 (3): 719–725.
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/